Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Myovant Sciences logo — is part of Sumitomo Pharma America as of July 2023

Myovant Sciences

is part of Sumitomo Pharma America as of July 2023

Founded 2016 United States Brisbane, United States 137 employees

General Information

Company Name Myovant Sciences
Founded Year 2016
Location United States Brisbane, United States +2
Employees 137
Social

Get notified when Myovant Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Myovant Sciences

This page is no longer active or monitored. Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive. Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines

No funding data available for Myovant Sciences yet.

Get notified when Myovant Sciences raises funding

Myovant Sciences Alternatives & Competitors

Myovant Sciences vs
Urovant Sciences
Urovant Sciences United States

is part of Sumitomo Pharma America as of July 2023

IPO
97 employees
Myovant Sciences vs
Sumitomo Pharma Oncology
Sumitomo Pharma Oncology United States

is part of Sumitomo Pharma America as of July 2023

49 employees
Health Care, Health and Wellness
Myovant Sciences vs
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. United States

is part of Sumitomo Pharma America as of July 2023

21 employees
Biotechnology, Pharmaceutical

FAQ About Myovant Sciences

is part of Sumitomo Pharma America as of July 2023
Myovant Sciences was founded in 2016.
Myovant Sciences is headquartered in Brisbane, United States.
Myovant Sciences has approximately 137 employees.
Top alternatives and competitors to Myovant Sciences include Urovant Sciences, Sumitomo Pharma Oncology, Sumitovant Biopharma, Inc., Astellas Pharma, Camino Pharma, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Myovant Sciences and Urovant Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Myovant Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy